Clinical Trial

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to obtain long-term follow-up information and status of bladder cancer for patients who received study treatment in the QUILT-2.005 study.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-07-31; most recent amendment 2026-04-28.
Status change: Recruiting → Active, Not Recruiting 2024-02-21
Status change: Not Yet Recruiting → Recruiting 2023-08-07
Trial Details
NCT Number NCT05981131
Lead Sponsor ImmunityBio, Inc.
Conditions Non Muscle Invasive Bladder Cancer
Enrollment 6 participants
Start Date 2023-08-17
Primary Completion 2033-08-30 (estimated)
Study Completion 2033-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-29